Anti‐program cell death receptor‐1 induced erythema nodosum

Saved in:
Bibliographic Details
Published inDermatologic therapy Vol. 35; no. 6; pp. e15443 - n/a
Main Authors Gerhardt, Caroline, Hennessy, Kerry, Morr, Claudia, Sarriera, Carlos J., Harkins, Andrea, Correa, Lilia
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.06.2022
Subjects
Online AccessGet full text
ISSN1396-0296
1529-8019
1529-8019
DOI10.1111/dth.15443

Cover

Author Hennessy, Kerry
Gerhardt, Caroline
Harkins, Andrea
Sarriera, Carlos J.
Morr, Claudia
Correa, Lilia
Author_xml – sequence: 1
  givenname: Caroline
  orcidid: 0000-0002-7212-207X
  surname: Gerhardt
  fullname: Gerhardt, Caroline
  email: cgerhardt@usf.edu
  organization: University of South Florida
– sequence: 2
  givenname: Kerry
  orcidid: 0000-0002-3611-0952
  surname: Hennessy
  fullname: Hennessy, Kerry
  organization: H. Lee Moffitt Cancer Center
– sequence: 3
  givenname: Claudia
  surname: Morr
  fullname: Morr, Claudia
  organization: University of South Florida
– sequence: 4
  givenname: Carlos J.
  surname: Sarriera
  fullname: Sarriera, Carlos J.
  organization: H. Lee Moffitt Cancer Center
– sequence: 5
  givenname: Andrea
  surname: Harkins
  fullname: Harkins, Andrea
  organization: H. Lee Moffitt Cancer Center
– sequence: 6
  givenname: Lilia
  orcidid: 0000-0001-6289-0465
  surname: Correa
  fullname: Correa, Lilia
  organization: H. Lee Moffitt Cancer Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35285117$$D View this record in MEDLINE/PubMed
BookMark eNp9kMtOwzAQRS0Eog9Y8AMoS1ik9diJG68QKo8iIbEp68i1JzQoj2I7Qt3xCXwjX4JLCwskmM2MNGdG994B2W_aBgk5ATqCUGPjlyNIk4TvkT6kTMYZBbkfZi5FTJkUPTJw7plSYJLDIenxlGUpwKRPLi4bX368va9s-2RVHWmsqsig8svIosaVb23YQlQ2ptNoIrRrv8RaRU1rWtfVR-SgUJXD410fkseb6_l0Ft8_3N5NL-9jzVnKY8gkGK0wkbxgCWbG8EkigGtJBafAmdFBGTLFFpoqBYIKkAkqLtKi0MHZkJxt_wahLx06n9el24hVDbady5ngmUwg4yKgpzu0W9Ro8pUta2XX-bfpAJxvAW1b5ywWPwjQfBNoHgLNvwIN7PgXq0uvfNk23qqy-u_itaxw_ffr_Go-2158AsizhuM
CitedBy_id crossref_primary_10_1007_s40278_022_20348_z
Cites_doi 10.1111/ajd.12970
10.1111/cup.13044
10.1016/j.jaad.2020.03.132
10.1016/j.jdcr.2021.05.002
10.1016/j.intimp.2018.06.001
10.1111/bcp.14433
10.5070/D3204022376
10.1177/1203475418776934
ContentType Journal Article
Copyright 2022 Wiley Periodicals LLC.
Copyright_xml – notice: 2022 Wiley Periodicals LLC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/dth.15443
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1529-8019
EndPage n/a
ExternalDocumentID 35285117
10_1111_dth_15443
DTH15443
Genre letter
Letter
Correspondence
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OC
24P
29F
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAJEY
AAKAS
AANHP
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABPVW
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCMX
ACCZN
ACGFS
ACMXC
ACPOU
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFGKR
AFPWT
AFZJQ
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
H13
HF~
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
RHX
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
XG1
YFH
ZZTAW
~IA
~WT
7X7
8FI
8FJ
AAFWJ
AAYXX
ABUWG
AFKRA
AGQPQ
BENPR
CCPQU
CITATION
FYUFA
HMCUK
PHGZM
PHGZT
PIMPY
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3253-1891dcae493f24e8dd374613c90630132dc931e2a2bc0aa1606194ea365ffc443
IEDL.DBID DR2
ISSN 1396-0296
1529-8019
IngestDate Fri Jul 11 15:27:21 EDT 2025
Thu Apr 03 07:03:32 EDT 2025
Thu Apr 24 23:02:43 EDT 2025
Tue Jul 01 04:10:36 EDT 2025
Wed Jan 22 16:24:31 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3253-1891dcae493f24e8dd374613c90630132dc931e2a2bc0aa1606194ea365ffc443
Notes content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ORCID 0000-0001-6289-0465
0000-0002-7212-207X
0000-0002-3611-0952
PMID 35285117
PQID 2638941836
PQPubID 23479
PageCount 2
ParticipantIDs proquest_miscellaneous_2638941836
pubmed_primary_35285117
crossref_primary_10_1111_dth_15443
crossref_citationtrail_10_1111_dth_15443
wiley_primary_10_1111_dth_15443_DTH15443
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2022
2022-06-00
2022-Jun
20220601
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: June 2022
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
PublicationTitle Dermatologic therapy
PublicationTitleAlternate Dermatol Ther
PublicationYear 2022
Publisher John Wiley & Sons, Inc
Publisher_xml – name: John Wiley & Sons, Inc
References 2021; 13
2019; 60
2018; 62
2021; 11
2020; 86
2018; 22
2020; 83
2017; 44
2014; 20
e_1_2_3_2_1
e_1_2_3_6_1
e_1_2_3_5_1
e_1_2_3_4_1
e_1_2_3_3_1
e_1_2_3_8_1
Seban RD (e_1_2_3_9_1) 2021; 11
e_1_2_3_7_1
e_1_2_3_10_1
References_xml – volume: 11
  issue: 5
  year: 2021
  article-title: Immune‐related erythema Nodosum mimicking in transit melanoma metastasis on [18F]‐FDG PET/CT
  publication-title: Diagnostics (Basel)
– volume: 62
  start-page: 29
  year: 2018
  end-page: 39
  article-title: Immune checkpoint blockade therapy for cancer: an overview of FDA‐approved immune checkpoint inhibitors
  publication-title: Int Immunopharmacol
– volume: 44
  start-page: 1080
  issue: 12
  year: 2017
  end-page: 1086
  article-title: Erythema nodosum‐like panniculitis mimicking disease recurrence: a novel toxicity from immune checkpoint blockade therapy—report of 2 patients
  publication-title: J Cutan Pathol
– volume: 86
  start-page: 1778
  issue: 9
  year: 2020
  end-page: 1789
  article-title: Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy
  publication-title: Br J Clin Pharmacol
– volume: 83
  start-page: 1255
  issue: 5
  year: 2020
  end-page: 1268
  article-title: Immune checkpoint inhibitor–related dermatologic adverse events
  publication-title: J Am Acad Dermatol
– volume: 20
  start-page: 22376
  issue: 4
  year: 2014
  article-title: Erythema nodosum—a review of an uncommon panniculitis
  publication-title: Dermatol Online J
– volume: 22
  start-page: 627
  issue: 6
  year: 2018
  end-page: 629
  article-title: Erythema Nodosum as the initial presentation of Nivolumab‐induced sarcoidosis‐like reaction
  publication-title: J Cutan Med Surg
– volume: 60
  start-page: 154
  issue: 2
  year: 2019
  end-page: 156
  article-title: A case of erythema nodosum‐like panniculitis induced by nivolumab in a patient with oesophageal cancer
  publication-title: Australas J Dermatol
– volume: 13
  start-page: 118
  year: 2021
  end-page: 120
  article-title: Erythema nodosum‐like panniculitis associated with immune checkpoint inhibitor therapy: two cases reporting a rare cutaneous adverse event
  publication-title: JAAD Case Rep
– ident: e_1_2_3_8_1
  doi: 10.1111/ajd.12970
– ident: e_1_2_3_6_1
  doi: 10.1111/cup.13044
– ident: e_1_2_3_4_1
  doi: 10.1016/j.jaad.2020.03.132
– ident: e_1_2_3_10_1
  doi: 10.1016/j.jdcr.2021.05.002
– ident: e_1_2_3_2_1
  doi: 10.1016/j.intimp.2018.06.001
– ident: e_1_2_3_3_1
  doi: 10.1111/bcp.14433
– ident: e_1_2_3_5_1
  doi: 10.5070/D3204022376
– ident: e_1_2_3_7_1
  doi: 10.1177/1203475418776934
– volume: 11
  issue: 5
  year: 2021
  ident: e_1_2_3_9_1
  article-title: Immune‐related erythema Nodosum mimicking in transit melanoma metastasis on [18F]‐FDG PET/CT
  publication-title: Diagnostics (Basel)
SSID ssj0012931
Score 2.3036344
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e15443
SubjectTerms Cell Death
Diagnosis, Differential
Erythema Nodosum - diagnosis
Humans
Receptors, Death Domain
Title Anti‐program cell death receptor‐1 induced erythema nodosum
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdth.15443
https://www.ncbi.nlm.nih.gov/pubmed/35285117
https://www.proquest.com/docview/2638941836
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEA6lB_Hi-1FfRPHgZctuNrvb4EGKtRShHqSFHoQlr0VRtqXdHvTkT_A3-kucZB9YHyDeFjYbspOZzHyTyReETj0WcaIS1wkipRzwt57DEgAr4IrA4QWuIPbUe_8m7A3p9SgY1dB5eRYm54eoEm7GMux6bQyci9knI1fZvUmLUMP06fmh4c3v3FbUUcaN5WDLFtmysGAVMlU81ZeLvuhbgLkYr1qH011Fd-VQ8zqTx-Y8E0358oXF8Z__soZWikAUt3PNWUc1nW6gpX6x1b6JLtpp9vD--lYUcGGT4cfKBIwYFkk9AawObz0MmB60Q2E9fbYEsDgFoAvqvYWG3avBZc8pbltwpE8C3_FazFOSa8r8hFDdUsqPKDh7yQwtF4BWJUGkmnAipMu5B8jHY1RzPwySRMLYt1E9Had6F-FQskSHrm4RxaiQQtjdWKmElGafM2igs1LusSyoyM2NGE9xCUlAILEVSAOdVE0nOf_GT42Oy8mLwTqMQHiqx_NZTExARmHZChtoJ5_VqhvDawPhZgSjsXPze_9xZ9CzD3t_b7qPlok5KWETNgeonk3n-hDil0wcWUX9AOzX6pg
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NAFH7UCurFfalrFA9eUpLJ1gFBilqitj1IC14kJDMTFCUtNT3oyZ_gb_SX-GayYF1AvAUyGSZv5s373jLfABya1AsJjw3d8TjX0d6aOo3RWUFThAbPMSKiTr13uq7fty9vnJsKHBdnYTJ-iDLgJjVD7ddSwWVA-pOW8_ROxkVsawqmVX5OQqLrkjxKGrLM3VJlttTNeYVkHU_56aQ1-gYxJxGrMjmtBbgtBptVmjzUx2lUZy9feBz_-zeLMJ9jUa2ZLZ4lqIhkGWY6ebZ9BU6aSXr__vqW13BpMsivcYkZNdwnxRDddXxraujW4wLhmhg9Kw5YLUFfF1f4KvRb571TX88vXNCZRRxLNxvU5CwUNrViYosG55Zno71nVDJzod_KGcpUkJBEzAhDE50fk9oitFwnjhmOfQ2qySARG6C5jMbCNUSDcGpHLIpUQpbxiDGZ6nRqcFQIPmA5G7m8FOMxKLwSFEigBFKDg7LpMKPg-KnRfjF7ASqIFEiYiMH4KSASk9m4c7k1WM-mtexGUtsg4vRwNGpyfu8_OOv56mHz7033YNbvddpB-6J7tQVzRB6cUPGbbaimo7HYQTiTRrtq1X4AnXbutg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5qheLF96M-o3jwktJsNmkXD1KspT5aRFroQQjJ7gZFSUtND3ryJ_gb_SXObh5YHyDeAtksm9mZnW9mZ78FOLRYzScirJpOTQgT_a1lshCDFXRF6PCcakD0qfdO12336cXAGRTgODsLk_BD5Ak3ZRl6vVYGPhLhJyMX8Z1Ki1B7Bmapi25SIaKbnDtK-bEk2tJVtsxNaYVUGU_-6bQz-oYwpwGr9jitBbjNxpoUmjxUJnFQ4S9faBz_-TOLMJ8iUaORqM4SFGS0DKVOute-AieNKL5_f31LK7gMleI3hEKMBq6ScoTBOr61DAzqUT2EIcfPmgHWiDDSRf1ehX7rrHfaNtPrFkxuE8c2rTqzBPclZXZIqKwLYdcoenvOFC8XRq2Co0gl8UnAq75vYehjMSp923XCkOPY16AYDSO5AYbLWSjdqqwTwWjAg0Bvx3IRcK42Op0yHGVy93jKRa6uxHj0spgEBeJpgZThIG86Sgg4fmq0n02eh-ahBOJHcjh58ohCZBTXLbcM68ms5t0oYhvEmzUcjZ6b3_v3mr22ftj8e9M9KF03W97VefdyC-aIOjWhkzfbUIzHE7mDWCYOdrXOfgDlau1l
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-program+cell+death+receptor-1+induced+erythema+nodosum&rft.jtitle=Dermatologic+therapy&rft.au=Gerhardt%2C+Caroline&rft.au=Hennessy%2C+Kerry&rft.au=Morr%2C+Claudia&rft.au=Sarriera%2C+Carlos+J&rft.date=2022-06-01&rft.eissn=1529-8019&rft.volume=35&rft.issue=6&rft.spage=e15443&rft_id=info:doi/10.1111%2Fdth.15443&rft_id=info%3Apmid%2F35285117&rft.externalDocID=35285117
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1396-0296&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1396-0296&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1396-0296&client=summon